Mwanzo8086 • TYO
add
Nipro Corp
Bei iliyotangulia
¥ 1,417.00
Bei za siku
¥ 1,414.00 - ¥ 1,426.50
Bei za mwaka
¥ 1,070.50 - ¥ 1,480.00
Thamani ya kampuni katika soko
243.39B JPY
Wastani wa hisa zilizouzwa
elfu 696.55
Uwiano wa bei na mapato
27.68
Mgao wa faida
1.76%
Ubadilishanaji wa msingi
TYO
Habari za soko
AP News
saa 7 zilizopita
CVS Health CEO Lynch steps down as national chain struggles to right its
path
5.23%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (JPY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 152.39B | 8.39% |
Matumizi ya uendeshaji wa biashara | 40.10B | 12.23% |
Mapato halisi | 2.63B | -35.94% |
Kiwango cha faida halisi | 1.72 | -41.10% |
Mapato kwa kila hisa | — | — |
EBITDA | 20.53B | 5.13% |
Asilimia ya kodi ya mapato | 50.72% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (JPY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 83.60B | -5.06% |
Jumla ya mali | 1.14T | 9.23% |
Jumla ya dhima | 852.26B | 7.68% |
Jumla ya hisa | 284.44B | — |
hisa zilizosalia | 163.10M | — |
Uwiano wa bei na thamani | 0.94 | — |
Faida inayotokana na mali | 1.29% | — |
Faida inayotokana mtaji | 1.58% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (JPY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.63B | -35.94% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. February 2018, the Company enters the endoscope-related business by making Machida Corporation its subsidiary.
April 1, 2019, the ethical pharmaceutical sales division of subsidiary Nipro ES Pharma Corporation is integrated into our domestic business division, Pharmaceutical Sales Division.
April 1, 2023, the Company's head office will be relocated to a new building constructed on the Company's own land in Kento Innovation Park in Settsu City. The registered head office and the location of the manufacturing and sales office based on the Law Concerning Assurance of Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices and Other Products are scheduled to be relocated in October of the same year. Wikipedia
Ilianzishwa
8 Jul 1954
Tovuti
Wafanyakazi
38,117
